P/E Ratio (TTM)
-354.82
Telix Pharmaceuticals Limited currently has a P/E ratio of -354.82. The P/E ratio is a primary valuation multiple used to determine if a stock is overvalued or undervalued relative to its earnings.
Quarterly P/E
| Quarter | P/E Ratio |
|---|---|
| 1999-01-31 | — |
| 1999-06-30 | — |
| 2000-01-31 | — |
| 2000-06-30 | — |
| 2000-09-30 | -14.98 |
| 2015-06-30 | -243.04 |
| 2015-12-31 | -243.04 |
| 2016-06-30 | 16.29 |
| 2017-01-31 | -15.83 |
| 2017-06-30 | -7.84 |
| 2017-12-31 | -8.57 |
| 2018-06-30 | -6.37 |
| 2018-12-31 | -3.88 |
| 2019-06-30 | -6.74 |
| 2019-12-31 | -5.39 |
| 2020-06-30 | -4.43 |
| 2020-12-31 | -9.24 |
| 2021-06-30 | -13.16 |
| 2021-12-31 | -11.42 |
| 2022-06-30 | -4.91 |
| 2022-12-31 | -17.32 |
| 2023-06-30 | -62.22 |
| 2023-12-31 | 41.77 |
| 2024-06-30 | 129.41 |
| 2024-12-31 | 53.29 |
| 2025-06-30 | -591.15 |
| 2025-12-31 | -128.61 |
Annual P/E
| Year | P/E Ratio |
|---|
* P/E ratios are calculated using trailing twelve-month (TTM) earnings. Extreme values may indicate earnings anomalies or cyclical volatility.